Trial intelligence / Profile preview

Therapeutic effect of TCA on anogenital warts

IRCT201307153566N3Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
May 2013
Modality
Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Countries
1
01

Overview

Phase 3 trial of trichloroacetic acid in anogenital warts, sponsored by Tabriz University of Medical Sciences. Started May 2013; status: completed.

02

Drugs

trichloroacetic acid
03

Conditions

anogenital warts

Beyond the preview

Go deeper on IRCT201307153566N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201307153566N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call